PLEASE DO NO QUOTE WITHOUT PERMISSION
One of the most significant changes in the organisation of health care in the past two decades has been the increase in calls and attempts to involve users and publics in the processes of decision making. The application of forms of patient and public involvement (PPI) in health care decision making is seen to be able to make services and interventions more responsive to the needs of the patients and more aligned with public views on aspects of health care organisation such as priority setting. It is argued that PPI can address the 'legitimacy problem' of a wide range of health care institutions (1) but there is still little knowledge about the relationship between procedures, processes and outcomes of PPI: who and how to involve, for what reasons, in which situations?
Health technology assessment (HTA) is identified as a key domain in this arena because of how it underpins much of the knowledge and evidence that is brought to bear in health care decision making. Some researchers have advocated that patientfocused HTA should reinforce the implementation of patient-centred care through the systematic evaluation of evidence on relevant preferences and views (2) . A recent literature review on patient and public involvement (PPI) on HTA processes found that patient and public representatives are mainly involved to provide evidence of needs and perspectives on the evaluation of technologies, but there is no systematic conceptualisation of the value and role of such contributions (3) . An international survey of PPI practices found that, while there is evidence to suggest PPI procedures are widespread, HTA organisations are unclear about how to share knowledge about their activities and what the value of that knowledge is for other institutions (4).
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These uncertainties are underpinned by a lack of theory regarding the knowledge and expertise brought by patient representatives and organisations to HTA processes.
Presently, patients' involvement in HTA is justified by the need to include 'experiential knowledge' of living with and managing an illness in the evaluation of the clinical, social, and ethical effects of using a healthcare technology (5) . Because illness experience varies across individual, social and cultural variables, there have been increased calls to systematise the integration of this type of knowledge by conducting primary or secondary research on patient perspectives (6) (3). To a significant degree, these proposals aim to address the ambiguous status of individual patients' perspectives both in HTA agencies and the social sciences, where some have argued that 'experiential knowledge' cannot be a robust base to evaluate the worth of research or technology (7) .
In this paper, I argue that research on patient involvement in HTA should shift from focusing on individual, embodied knowledge, derived from living with an illness, towards an understanding of knowledge as amassed and deployed by networks of variable complexity. Indeed, in Borkman's original formulation of the concept of 'experiential knowledge', expertise was derived from the collection, comparison and sorting of individual experiences in self-help groups; it was collectively produced and distributed across members of the group (8) . Although such 'experiential knowledge' is usually seen in opposition to professional knowledge, particularly with the emergence of health social movements that specifically challenged established expertise from the 1960s (9), patient organisations have diversified the range of networks in which they participate (10) and expanded their repertoire of knowledgerelated activities, increasingly collaborating across expertise lines (11) . In our crossnational, European study of patient organisations involvement in knowledge generation, dissemination and use, we have found that condition-focused organisations varyingly articulate the collection and shaping of experiential knowledge with credentialed knowledge, some of them becoming part and parcel of networks of established expertise (12) . Publicly assuming this hybrid epistemic identity provides some patient organisations and their members with a capacity to intervene in and shape 'evidence-based' policy environments, including their participation in HTA research and forums, while others remain attached solely to their 'experiential knowledge'. This paper aims thus to contribute to the understanding of the processes by which groups or citizens become involved in public issues around health technologies (13) (14) (15), by asking two related questions: a) What knowledge-related activities are patient organisations involved in?, and b) How are these knowledge activities related to the networks in which the patient organisation is embedded in? In the paper, I will address these questions by using the case of the Alzheimer's Society (AS), the leading patient organisation for persons living with dementia and their carers in England and Wales. The case was integrated in the European study referred above and described in the Methods section, and is used in here because it represents an instance where high involvement in shaping research in HTA is associated with a strong historical integration in expert and policy network both nationally and globally. The relationship between involvement and network integration shapes the organisations' epistemic identity: how organisations construct their own role as knowledge producers; the value they ascribe to knowledge; and their understanding of the value and relationship between different types of knowledge. Below, I explore how the AS has actively transformed its epistemic identity by mobilising, extending and deepening collaborative links with clinicians, researchers and policy makers. This entailed questioning its sole reliance on 'experiential knowledge' as a basis to participate in the public shaping of dementia policy, and pursuing instead an identity that values the combination of experiential, clinical and scientific knowledge forms. In the Discussion, I will suggest that the case of the AS should be placed within a typology for patient and patient organisation involvement in HTA that could, with basis on more research, guide analysis and integration of users' views in HTA.
Methods
A case-study is usually defined as a detailed exploration of a single event, process or setting. Recognised as a crucial methodology in the social sciences and as integral to social science reasoning (16) , case study research aims to use cases to tease out and identify dimensions, conditions and relationships within social phenomena. As such, case-studies are also widely recognised for how they support the identification of The analysis of the data for the case study presented in this paper followed an analytical induction approach, a species of case-based reasoning whereby instances are outlined and analysed in close and iterative relationship with the formulation of hypotheses (17) . Three modules in this iterative process of analysis can be identified: a) initial analytical propositions were composed through constant comparison across data items; b) these propositions were further developed and stabilised in a 'coding manual'; c) using the 'coding manual', data was systematically coded, identifying deviant cases that enabled the revision and expansion of the coding manual. The analysis was further validated with triangulation across data sets collected in the project.
The project was approved by the Ethics Committee of the School of Applied Social Sciences, Durham University, drawing on guidance from the Economic and Social
Research Council and the European Commission. Due to the public profile of the interviewees, it was agreed that that they would not require anonymisation of transcripts but would have access to the final transcript used in analysis. All the other data collected was in the public domain.
Results
In this section, I explore the dynamic relationship between the forms of knowledge assembled and deployed by one patient organisation and the networks of expertise and policy it mobilised to pursue its activities. I identify three phases of this dynamic in the history of the AS. In the first period, the AS established its epistemic identity around 'caring knowledge' by drawing on its volunteer membership, links with clinical specialists and support from the State. In a transition stage, the AS rearticulated its identity as a combination of experiential, clinical and scientific knowledge in an attempt to redraw its relationship with volunteers and to expand its field of activism into HTA. In the most recent phase, the AS deepens and expands its network of associations to secure its role in the production of evidence that is brought to bear in health policy making.
Becoming a carer organisation Established in 1979 as the result of the cooperation between two former carers and two clinicians, the AS set its mission to be the provision of carer mutual support and of information on the relatively less known illness to members and the public. Organisation of type B aim to diversify their knowledge engagement but show asymmetries in their ability to participate in some networks. They might, like the AS during its transition period, be locked into particular networks or unable to link effectively to others. Weak focused (C) organisations are those that invest in one type of knowledge -say, experiential knowledge -linked to one kind of networkmembers. Finally, robust focused organisations are those able to incorporate their specific, unique knowledge form as a key contribution to a wider process of knowledge making. This could be 'experiential knowledge' when this is used specifically in the re-making of expert knowledge about particular illnesses, for example. This typology, as most in the social sciences, is not intended a discrete, rigid classification of species of organisations but rather as a conceptual tool to understand the patient organisations' epistemic identities, and their dynamic.
HTA agencies and researchers wanting to integrate patient representatives and patient organisations in assessment processes could draw on this tool to make sense of the contribution they can make. Framing their possible contribution only in terms of 'perspectives' and 'experiential knowledge' risks not only wasting relevant knowledge but also creating preventable conflict around PPI. Moreover, using this model would underpin PPI in HTA on a sound theoretical basis that acknowledges the diversity of forms of engagement of patient organisations with knowledge making.
This would mean relying less on the expert-lay boundary and delineate HTA as openmembership 'hybrid forums' where experts, practitioners and patients collectively articulate the relationship between the evidence-base and contexts of use of technology (26, 27) .
A key limitation of the typological model presented here is that it is based on a single case study. As explained in the Methods section, the model was devised through the use of analytical induction and validated across the varieties of data set gathered for the project. This does not mean, however, that the model is proposed as a finished conceptual tool. It is indeed one of the features of analytical induction that models are proposed as working hypotheses. As a form of case-based reasoning, analytic 
